Virtual clinical trials, a reliance on telemedicine and remote monitoring have brought many changes to clinical trials. Adapting to the ever-changing landscape requires flexibility when crafting and modifying clinical trial agreements. DGE’s 3rd Clinical Trial Agreements Forum is designed to walk you through important changes impacting CTAs including incorporating cybersecurity language, more complicated indemnification, complexities of third party contracting and an increase in remote monitoring. The conference agenda provides insight into industry best practices and legal and technological trends impacting success plus ways to expedite contracting and study start up.
- Recognize the top challenges in negotiating CTAs from sites and sponsors
- Gain insight on informed consent and future use of patient data and samples
- Define the patient injury provision in subcontracts and clinical trial agreements
- Hear about strategies to manage negotiation timelines effectively and efficiently
- Incorporate cybersecurity language in CTAs and remote monitoring agreements
Professionals of Biopharma and Medial Device companies working in the areas of:
- Clinical Research
- Clinical Contracts
- Clinical Operations
- Clinical Development and Analytics
- General/Senior Counsel
- Site/Global Site Agreements
- Regulatory Officer
- Clinical Compliance
- Supply Manager
- Clinical Project Manager
- Medical Director
- Quality and Compliance
- Clinical Pharmacology
Stay up to date on the latest announcements